Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05666050
Other study ID # JUIH/IRB/230/22
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 5, 2022
Est. completion date April 25, 2023

Study information

Verified date December 2022
Source Wollo University
Contact Niguss Cherie, MPH
Phone 0910749743
Email nigucheru@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Effectiveness of interactive mobile health intervention (IMHI) to improve neonatal care practice among postpartum women in Dessie and Kombolcha town zones, north east Ethiopia: behavioral cluster randomized control trial.


Description:

The main aim of this study is to determine effectiveness of mobile health intervention to improve neonatal care practice among postpartum women in Dessie and Kombolcha town zones, North east Ethiopia. First participants will be grouped in to two arms based on randomization of clusters. The intervention arm will take the new intervention with existed health care practice and the control arm will take the existed current health care practice. The intervention arm will receive sending message service (SMS) over a four month period (90 days pre-natal and 42 days post-partum) and the control arm will receive the existed health care practice. Participants in the intervention arm will receive mobile based health education and health communication messages as well as messages on neonatal care practice based on national maternal and child health care education and counseling guidelines. Participants in this study will be randomly assigned as intervention will receive sending message service from a trained professional; while participants assigned to control group will not receive phone based interventions but can contact their health care providers as routine health facility activity. Initially, study participants will receive one text message every two weeks with the frequency increasing to messages for 42 days following delivery. Pregnant women with 26-28 weeks of gestation(based on world health organization eligibility criteria) will be recruited and baseline data will be collected at selected clusters. Women who will provide informed consent will be asked to complete a post-consent eligibility assessment including access to a mobile phone, and willingness to receive health messages on their mobile phone. Women who meet these eligibility criteria will be enrolled in the study and administered the baseline interview. Intervention will be started among randomly selected clustered pregnant women at 30 weeks of gestation and continued up to 6 weeks of post par-tum period for 4 months. Three intervention worker female nurses/midwifes will be recruited and trained to do the intervention based on the protocol After this end line data will be collected from both intervention and control group.


Recruitment information / eligibility

Status Recruiting
Enrollment 784
Est. completion date April 25, 2023
Est. primary completion date April 25, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 49 Years
Eligibility Inclusion Criteria: - Pregnant women 26-28 weeks of gestation and have mobile phone access in the study area. Exclusion Criteria: - Pregnant women seriously ill and not able to respond.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mobile health intervention
Pregnant women with 26-28 weeks of gestation(based on world health organization eligibility criteria) will be recruited and baseline data will be collected at selected clusters. Women who will provide informed consent will be asked to complete a post-consent eligibility assessment including access to a mobile phone, and willingness to receive health messages on their mobile phone. Women who meet these eligibility criteria will be enrolled in the study and administered the baseline interview. Intervention will be started among randomly selected clustered pregnant women at 30 weeks of gestation and will be continued up to 6 weeks of post partum period for 4 months.

Locations

Country Name City State
Ethiopia Dessie and Kombolcha Dessie South Wollo

Sponsors (2)

Lead Sponsor Collaborator
Wollo University Jimma University

Country where clinical trial is conducted

Ethiopia, 

References & Publications (1)

Cherie N, Abdulkerim M, Abegaz Z, Walle Baze G. Maternity continuum of care and its determinants among mothers who gave birth in Legambo district, South Wollo, northeast Ethiopia. Health Sci Rep. 2021 Nov 2;4(4):e409. doi: 10.1002/hsr2.409. eCollection 20 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Neonatal care practice among the intervention and control group will be measured by The minimum WHO 12 items will be used to produce composite index (score). Principal component analysis will be done to create composite index (score) and respondents who will have scored above or equal to the mean/median value will be considered as having good neonatal care, while those who will score below the mean/median value were considered as poor neonatal care. Two weeks after intervention the outcome will be measured.
See also
  Status Clinical Trial Phase
Completed NCT03942536 - The MOMENTUM Study (Monitoring Maternal Emergency Navigation and Triage on Mfangano
Recruiting NCT05294276 - Prospective Registration of Taiwan Neonatal Network (TNN)
Recruiting NCT05517577 - An Integrated Community-based Intervention Package in Improving Maternal and Neonatal Health Outcomes N/A